Co-Diagnostics, Inc. CODX
Set alert
At close · Nov 2
After hours · Nov 2, 4:31 PM ET
- YTD
- -93.03%
- 1 year
- -97.44%
- Open
- 0.3921
- Prev close
- 0.3667
- Mkt cap
- 3.12M
- Vol
- 590.83K
- Avg vol
- 359.31K
- EPS
- -26.01
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.35
- High
- 0.4178
- Forward P/E
- -0.62
- Beta
- -0.85
- Short ratio
- 1.77
- Inst. own
- 13.96%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 1.06
- 200-d avg
- 1.19
- 1y target
- 1.50
6M chart
Signals (23)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 15, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 14, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 13, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 12, 2026 | 3 weeks ago |
| RSI: Oversold | Sep 16, 2026 | 1 month ago |
| RSI: Oversold | Sep 8, 2026 | 1 month ago |
| RSI: Oversold | Aug 17, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 7, 2026 | 2 months ago |
| RSI: Oversold | Aug 6, 2026 | 2 months ago |
| RSI: Oversold | Jul 28, 2026 | 3 months ago |
| SMA: Bearish | Jul 6, 2026 | 3 months ago |
| SMA: Bearish | Jun 25, 2026 | 4 months ago |
| SMA: Bullish | Jun 24, 2026 | 4 months ago |
| SMA: Bearish | Jun 22, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 5, 2026 | 5 months ago |
| SMA: Bullish | May 21, 2026 | 5 months ago |
| RSI: Overbought | May 21, 2026 | 5 months ago |
| SMA: Bullish | May 19, 2026 | 5 months ago |
| MACD: Buy Signal | May 19, 2026 | 5 months ago |
| MACD: Sell Signal | May 15, 2026 | 5 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
| SMA: Bullish | May 8, 2026 | 5 months ago |
| RSI: Overbought | May 8, 2026 | 5 months ago |
News
4 days ago prnewswire.com
Co-Diagnostics Announces Third Quarter 2026 Earnings Release Date and Webcast
SALT LAKE CITY, Oct. 29, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of…
-
4 days ago benzinga.com
Co-Diagnostics Announces Publication Of Peer-Reviewed Study Using SARAGENE Human Papillomavirus High Risk Test Manufactured By CoSara Diagnostics
Follow-Up Biopsies Identified High-Grade Lesions or Cervical Cancer in 12 of 20 HPV-Positive Women, Including a Cohort with Predominantly Negative Cytology ResultsCoSara to Exhibit at MICROCON 2026,…
4 days ago prnewswire.com
Co-Diagnostics' Joint Venture CoSara Diagnostics Announces Publication of Peer-Reviewed HPV Screening Study Using CoSara's SARAGENE® Test
Follow-Up Biopsies Identified High-Grade Lesions or Cervical Cancer in 12 of 20 HPV-Positive Women, Including a Cohort with Predominantly Negative Cytology Results CoSara to Exhibit at MICROCON 2026,…
6 days ago benzinga.com
Co-Diagnostics Moves Closer to Commercial Tuberculosis Test Launch in India
Co-Diagnostics filed for Indian clearance for its rapid TB test following successful trials, targeting commercial sales before the year-end.
-
6 days ago benzinga.com
Co-Diagnostics's India JV CoSara Diagnostics Completes Its Clinical Performance Study Of The CoSara PCR Mycobacterium Tuberculosis Test On CoSara PCR Pro Instrument; Has Submitted Test To India's Central Drugs Standard Control Organization For Regulatory Clearance
The submission follows the Company's July 22, 2026 announcement that CoSara had initiated clinical studies for the CoSara PCR MTB test across select laboratories in India. The clinical study assessed…
6 days ago prnewswire.com
Co-Diagnostics' Joint Venture CoSara Diagnostics Completes Clinical Study and Regulatory Submission for Point-of-Care Tuberculosis Test, Sets Stage for Commercial Launch in India
CDSCO Clearance and Commercial Launch in India Anticipated Before Year-End 2026 Study Demonstrated 97.3% Sensitivity and 96.0% Specificity Consistent Performance Across Three Test Batches Integrated…
1 week ago prnewswire.com
Co-Diagnostics' Joint Venture CoMira Diagnostics Invited by Saudi Ministry to Participate in Strategic Manufacturing Forum
Participation in NUWATIN 2026 to Support Advancement of Strategic Manufacturing, Technology Transfer, and Industrial Localization Initiatives Under Saudi Vision 2030 Invitation Follows Execution of…
2 weeks ago prnewswire.com
Co-Diagnostics Highlights PCR Platform Capabilities for Potential Plague Detection
Existing Sputum Sample-Preparation Technology Provides Potential Foundation for Plague Diagnostics Draws on Rapid-Response Experience with COVID-19, Mpox and Ebola Supported by Expanded Manufacturing…
3 weeks ago prnewswire.com
Co-Diagnostics Announces First Full Vector Smart® Laboratory Installation for Native American Tribe
Ute Indian Tribe Mosquito Abatement Department to bring PCR-based mosquito surveillance testing in house SALT LAKE CITY, Oct. 8, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or…
3 weeks ago prnewswire.com
Co-Diagnostics Highlights Vector Smart® Momentum Following New Federal Initiative on Vector-Borne Disease
New Executive Order prioritizes improved detection and calls for federal R&D programs for rapid diagnostics for mosquito- and tick-borne diseases Company to participate in October 9 Utah Global…
-
3 weeks ago benzinga.com
Co-Diagnostics To Demonstrate Co-Dx PCR Platform, MTB Test At WHX Labs
Co-Diagnostics, Inc. (NASDAQ:CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced its
3 weeks ago prnewswire.com
Co-Diagnostics to Showcase Co-Dx PCR Platform* and MTB Test at WHX Labs Johannesburg, Highlight Ebola Assay Development
Ebola Assay in Development for Decentralized Testing on the Co-Dx PCR Platform SALT LAKE CITY, Oct. 6, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular…
1 month ago defenseworld.net
Head to Head Review: Halozyme Therapeutics (NASDAQ:HALO) & Co-Diagnostics (NASDAQ:CODX)
Halozyme Therapeutics (NASDAQ: HALO - Get Free Report) and Co-Diagnostics (NASDAQ: CODX - Get Free Report) are both healthcare companies, but which is the better business? We will contrast the two…
1 month ago prnewswire.com
Co-Diagnostics to Participate in Global Health Events During UN General Assembly Week
Events Bring Together Global Health Leaders to Examine Tuberculosis and Preparedness for the Next Respiratory Pandemic SALT LAKE CITY, Sept. 23, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq:…
1 month ago prnewswire.com
Co-Diagnostics to Participate in Global Health Roundtable on Ebola and Outbreak Innovation
Roundtable discussion, taking place in New York City, will examine the ongoing Ebola outbreak and technologies needed to strengthen future outbreak response. Co-Dx will join officials from the U.S.…
1 month ago prnewswire.com
Co-Diagnostics to Participate in Joint WHO/Unitaid/UNAIDS Annual Consultation Meeting on September 17-18, 2026
SALT LAKE CITY, Sept. 17, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of…
1 month ago seekingalpha.com
Co-Diagnostics, Inc. (CODX) Shareholder/Analyst Call Transcript
Co-Diagnostics, Inc. (CODX) Shareholder/Analyst Call Transcript
1 month ago prnewswire.com
Co-Diagnostics and ReadyGo Collaborate to Evaluate Blood-Based Molecular Testing at the Point of Need, Starting with Ebola
Blood-based testing could open new markets for the Co-Dx® PCR platform, including HIV and hepatitis B and C Co-Diagnostics and ReadyGo target decentralized Ebola detection as the first application of…
1 month ago prnewswire.com
Co-Diagnostics to Hold Press Conference
Media, analysts and investors are welcome to attend in person or via live webcast, Sept. 16 at 10:30 a.m.
-
1 month ago benzinga.com
Co-Diagnostics Enters Material Transfer Agreement With ReadyGo Diagnostics To Evaluate Sample Preparation Technologies For Co-Dx PCR Platform; Material Transfer Agreement Does Not Obligate Either Party To Enter Into Any Development, Supply, Commercialization Or Other Commercial Arrangement
In August 2026, Co-Diagnostics, Inc. (the "Company") entered into a material transfer agreement with ReadyGo Diagnostics Ltd ("ReadyGo") to evaluate the potential compatibility of certain ReadyGo…
1 month ago prnewswire.com
Co-Diagnostics Completes New Vector Smart® Laboratory Installations Amid Rising Dengue Activity in Florida
Two full laboratory installations completed in Florida; installation and customer training underway in Indiana State surveillance has recorded 73 locally acquired dengue cases and identifies 14…
1 month ago benzinga.com
Stock Market Today: S&P 500, Dow, Nasdaq 100 Futures Fall as Oil Tops $99 Despite Trump’s Price Drop Prediction— ASML, NVS, CASY in Focus (UPDATED)
Stock Market Today: S&P 500, Dow Futures Fall as Oil Tops $99 Despite Trump’s Price Drop Prediction— ASML, NVS, CASY in Focus
1 month ago benzinga.com
United Natural Foods, ABM Industries and 3 Stocks to Watch Heading Into Tuesday
Stocks in focus: UNFI and ABM earnings, Novartis trial miss, Co-Diagnostics CFO change, and Casey’s earnings expected.
-
1 month ago benzinga.com
Co-Diagnostics CFO Brian Brown Departs Company; Appoints Daniel Bohrer As Principal Financial Officer, Effective September 2, 2026
On September 2, 2026, Co-Diagnostics, Inc. (the "Company") and Brian Brown, the Company’s Chief Financial Officer, determined that Mr. Brown’s last day of employment with the Company would be…
2 months ago prnewswire.com
Co-Diagnostics Launches Integrated Cloud and Mobile Infrastructure in India
Localized cloud environment is designed to support ongoing clinical studies and establish the digital foundation for future data commercialization strategies SALT LAKE CITY, Sept. 3, 2026…
2 months ago prnewswire.com
Co-Diagnostics Expands Vector Smart® Customer Reach with First International Installation in USAF Base
Shipments of laboratory equipment and other mosquito abatement materials to overseas USAF base represent first international expansion of Vector Smart product line SALT LAKE CITY, Sept. 1, 2026…
-
2 months ago benzinga.com
World Health Organization Director General Determined That The Ebola Epidemic In DRC Still Meets Criteria Of Public Health Emergency Of International Concern, But Not Those Of A Pandemic Emergency
https://www.who.int/news/item/28-08-2026-second-meeting-of-the-ihr-emergency-committee-on-the-epidemic-of-ebola-bundibugyo-virus-disease-in-the-democratic-republic-of-the-congo---meeting-report
2 months ago prnewswire.com
Co-Diagnostics Participates in Medical Devices and Innovations Roundtable Media Event
Company Chief Commercialization Officer represented Co-Dx in an event featuring other industry stakeholders held on August 13 in Salt Lake City, UT SALT LAKE CITY, Aug. 18, 2026 /PRNewswire/ --…
2 months ago seekingalpha.com
Co-Diagnostics, Inc. (CODX) Q2 2026 Earnings Call Transcript
Co-Diagnostics, Inc. (CODX) Q2 2026 Earnings Call Transcript
2 months ago benzinga.com
Co-Diagnostics Reports Q2 2026 Results: Full Earnings Call Transcript
On Thursday, Co-Diagnostics (NASDAQ:CODX) discussed second-quarter financial results during its earnings call. The full transcript is provided below. Benzinga APIs provide real-time access to…
-
2 months ago benzinga.com
Co-Diagnostics Q2 EPS $(1.46) Beats $(3.00) Estimate, Sales $166.131K Miss $166.500K Estimate
Co-Diagnostics (OTC:CODX) reported quarterly losses of $(1.46) per share which beat the analyst consensus estimate of $(3.00) by 51.33 percent. This is a 78.84 percent increase over losses of $(6.90)…
3 months ago benzinga.com
Merck-Backed Lab Gets $8.5 Million to Fast-Track a Vaccine for a Rapidly Spreading Ebola Outbreak
Merck and Wellcome-backed Hilleman will manufacture Bundibugyo Ebola vaccine doses for clinical trials with up to $8.5M in CEPI funding.
-
3 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Autonomix Medical (NASDAQ:AMIX) shares increased by 89.4% to $5.21 during Wednesday's regular session. The market value of their outstanding shares is at $1.4 million. SciSparc (NASDAQ:SPRC)…
3 months ago benzinga.com
EXCLUSIVE: Co-Diagnostics Announces Successful Proof of Concept for Extraction-Free Ebola Test
Co-Diagnostics advances its Ebola testing capabilities, sending Bundibugyo virus test kits for evaluation and completing a new assay study.
3 months ago benzinga.com
Why Forte Biosciences Shares Are Trading Higher By 39%; Here Are 20 Stocks Moving Premarket
Forte Biosciences shares rose 38.9% to $76.10 in pre-market trading after argenx SE announced plans to acquire the company for $77 per share.
3 months ago benzinga.com
EXCLUSIVE: Co-Diagnostics Marks New Milestone as India TB Test Clinical Studies Begin
Co-Diagnostics' India joint venture CoSara has started clinical studies for its rapid TB PCR test, advancing deployment of its point-of-care platform.
4 months ago benzinga.com
EXCLUSIVE: Co-Diagnostics Reaches Regulatory Milestone for PCR Respiratory Test Platform
Co-Diagnostics completed clinical and analytical studies for its PCR Flu A/B & RSV test and plans FDA 510(k) and CLIA waiver submissions.
-
4 months ago benzinga.com
Co-Diagnostics Announces Delegation Visit From CoMira Diagnostics At Co. Headquarters In Salt Lake City; Unveils Future Automated Production Line At Technology, Innovation Event
Co-Diagnostics, Inc. (NASDAQ:CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that…
4 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
-
4 months ago benzinga.com
Co-Diagnostics Enters Into Exclusive Distribution Agreement With Partner In Mexico For Co-Dx PCR Point-Of-Care Platform
Longstanding distribution partner to support future deployment of Co-Dx™ PCR Pro® and expanding menu of molecular diagnostics products across a key Latin American marketSALT LAKE CITY, June 11, 2026
-
5 months ago benzinga.com
U.S. State Dept Announces Nearly $38M In Additional Funding Toward The Department's Ongoing Ebola Response Efforts
https://www.state.gov/releases/office-of-the-spokesperson/2026/06/ebola-response-update-june-5-2026/
-
5 months ago benzinga.com
Co-Diagnostics Advances Dual Ebola PCR Testing Program To Enhance Outbreak Detection And Surveillance In Africa
Dual-assay strategy designed to support outbreak response and surveillance efforts in affected regionsPotential blood-based Ebola assay would represent an important expansion of Co-Dx™ PCR…
5 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Monday's Intraday Session
-
5 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Friday's Intraday Session
-
5 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Thursday's Intraday Session
-
5 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
-
5 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
-
5 months ago benzinga.com
Co-Diagnostics Advances Its PCR Assay Development Strategy For The Bundibugyo Virus, Aided By Cosara Diagnostics JV
Co-Diagnostics, Inc. (NASDAQ:CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that…
-
5 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
5 months ago benzinga.com
Why JOYY Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Gainers: PHGE +97.3%, ARTL +74.8%, QTEX +52.4%, MNTX +34.4%, HLIT +28.3%, WOK +25%, CPSH +24.7%, CODX +22.7%, MDAI +22%. Losers: AKTX -25.2%, RYOJ -18.6%, DEVS -18.6%, AKAN -17%, ADTX -16.3%, LFS…